{"id":37002,"date":"2019-12-13T08:00:51","date_gmt":"2019-12-13T08:00:51","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=37002"},"modified":"2020-04-17T21:11:33","modified_gmt":"2020-04-17T21:11:33","slug":"htb-13-december-2019-online","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/37002","title":{"rendered":"HTB 13 December 2019 online"},"content":{"rendered":"<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2019\/12\">Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/12\/HTB-13-Dec-2019-no-14-2-column.pdf\" rel=\"noopener noreferrer\">PDF of this issue<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe by email<\/a><\/li>\n<\/ul>\n<p><b><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-37005 \" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/12\/HTB-13-Dec-2019-no-14-cover-209x300.png\" alt=\"\" width=\"192\" height=\"259\" \/><\/b><\/p>\n<p>This final edition of HTB continues our reports from the 17th EACS conference recently held in Basel.<\/p>\n<p>These include early data on a long acting (6-monthly) capsid inhibitor for MDR HIV, a review of dual therapy with dolutegravir\/lamivudine, the lack of weight gain with doravirine, and an analysis on bone and renal changes in the ADVANCE study.<\/p>\n<p>We also include a report on HIV loneliness from the recent workshop on HIV and Ageing.<\/p>\n<p>ARV news includes: new UK access to doravirine, FDA submission for fostemsavir (but now on named patent access) and submission of a new paediatric formulation of dolutegravir.<\/p>\n<p>Over the last few months i-Base has updated three treatment guides &#8211; see below &#8211; and we proudly distribute these free.<\/p>\n<p>However, any loose change you have during the holiday season could find a worse home that the i-Base appeal.<\/p>\n<p><strong><em>Thank you to all our supporters who have contributed&#8230;<\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EACS: Capsid inhibitors, DTG\/3TC, doravirine, ADVANCE bone and renal&#8230; loneliness and ageing&#8230;plus more&#8230;<\/p>\n","protected":false},"author":3,"featured_media":37044,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-37002","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/37002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=37002"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/37002\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media\/37044"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=37002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=37002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=37002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}